{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T04:33:38Z","timestamp":1754109218264},"reference-count":41,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T00:00:00Z","timestamp":1373932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0068039","type":"journal-article","created":{"date-parts":[[2013,7,16]],"date-time":"2013-07-16T21:06:20Z","timestamp":1374008780000},"page":"e68039","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":11,"title":["Passive Immunization with Hypochlorite-oxLDL Specific Antibodies Reduces Plaque Volume in LDL Receptor-Deficient Mice"],"prefix":"10.1371","volume":"8","author":[{"given":"Marcella","family":"van Leeuwen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Kemna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Menno P. J.","family":"de Winther","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis","family":"Boon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adriaan M.","family":"Duijvestijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darius","family":"Henatsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nico A.","family":"Bos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion J. J.","family":"Gijbels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Willem Cohen","family":"Tervaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2013,7,16]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrd3444","article-title":"Anti-inflammatory therapeutics for the treatment of atherosclerosis","volume":"10","author":"IF Charo","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/nri1882","article-title":"The immune response in atherosclerosis: a double-edged sword","volume":"6","author":"GK Hansson","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"ref3","first-page":"176","article-title":"Active and passive immunization for atherosclerosis","volume":"9","author":"KY Chyu","year":"2007","journal-title":"Curr Opin Mol Ther"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.autrev.2009.03.001","article-title":"The therapeutic potential of targeting B cells and anti-oxLDL antibodies in atherosclerosis","volume":"9","author":"M van Leeuwen","year":"2009","journal-title":"Autoimmun Rev"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.atherosclerosis.2005.11.033","article-title":"Passive immunization with monoclonal IgM antibodies against phosphorylcholine reduces accelerated vein graft atherosclerosis in apolipoprotein E-null mice","volume":"189","author":"JR Faria-Neto","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"190","DOI":"10.2174\/138945008783755520","article-title":"Natural antibodies in murine atherosclerosis","volume":"9","author":"CJ Binder","year":"2008","journal-title":"Curr Drug Targets"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1194\/jlr.R500005-JLR200","article-title":"Thematic review series: The Immune System and Atherogenesis. The role of natural antibodies in atherogenesis","volume":"46","author":"CJ Binder","year":"2005","journal-title":"J Lipid Res"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1161\/hq0801.093587","article-title":"Human-derived anti-oxidized LDL autoantibody blocks uptake of oxidized LDL by macrophages and localizes to atherosclerotic lesions in vivo","volume":"21","author":"PX Shaw","year":"2001","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1172\/JCI200420479","article-title":"IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis","volume":"114","author":"CJ Binder","year":"2004","journal-title":"J Clin Invest"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1038\/nm876","article-title":"Pneumococcal vaccination decreases atherosclerotic lesion formation: molecular mimicry between Streptococcus pneumoniae and oxidized LDL","volume":"9","author":"CJ Binder","year":"2003","journal-title":"Nat Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1161\/01.CIR.0000092891.55157.A7","article-title":"Immunoglobulin M Type of Autoantibodies to Oxidized Low-Density Lipoprotein Has an Inverse Relation to Carotid Artery Atherosclerosis","volume":"108","author":"J Karvonen","year":"2003","journal-title":"Circulation"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.atherosclerosis.2005.10.017","article-title":"Antibodies of IgM subclass to phosphorylcholine and oxidized LDL are protective factors for atherosclerosis in patients with hypertension","volume":"188","author":"J Su","year":"2006","journal-title":"Atherosclerosis"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.clim.2009.08.013","article-title":"Low level natural antibodies against phosphorylcholine: A novel risk marker and potential mechanism in atherosclerosis and cardiovascular disease","volume":"134","author":"J Frosteg\u00e5rd","year":"2010","journal-title":"Clinical Immunology"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"Caidahl K, Hartford M, Karlsson T, Herlitz J, Pettersson K, <etal>et al<\/etal>.. (2012) IgM-phosphorylcholine autoantibodies and outcome in acute coronary syndromes. Int J Cardiol.","DOI":"10.1016\/j.ijcard.2012.01.018"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1161\/01.ATV.0000163262.83456.6d","article-title":"Myeloperoxidase and cardiovascular disease","volume":"25","author":"SJ Nicholls","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1172\/JCI5549","article-title":"Myeloperoxidase-generated reactive nitrogen species convert LDL into an atherogenic form in vitro","volume":"103","author":"EA Podrez","year":"1999","journal-title":"J Clin Invest"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI117342","article-title":"Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions","volume":"94","author":"A Daugherty","year":"1994","journal-title":"J Clin Invest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1056\/NEJMoa035003","article-title":"Prognostic value of myeloperoxidase in patients with chest pain","volume":"349","author":"ML Brennan","year":"2003","journal-title":"N Engl J Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1001\/jama.286.17.2136","article-title":"Association between myeloperoxidase levels and risk of coronary artery disease","volume":"286","author":"R Zhang","year":"2001","journal-title":"Jama"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.amjmed.2003.10.025","article-title":"Myeloperoxidase polymorphism related to cardiovascular events in coronary artery disease","volume":"116","author":"FW Asselbergs","year":"2004","journal-title":"Am J Med"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1365-2249.2007.03420.x","article-title":"Anti-oxidized low-density lipoprotein antibodies in myeloperoxidase-positive vasculitis patients preferentially recognize hypochlorite-modified low density lipoproteins","volume":"149","author":"MC Slot","year":"2007","journal-title":"Clin Exp Immunol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2009.04657.x","article-title":"The IgM response to modified LDL in experimental atherosclerosis: hypochlorite-modified LDL IgM antibodies versus classical natural T15 IgM antibodies","volume":"1173","author":"M van Leeuwen","year":"2009","journal-title":"Ann N Y Acad Sci"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1161\/STROKEAHA.110.592725","article-title":"Autoantibodies Against Oxidized Low-Density Lipoprotein in Cerebral Small Vessel Disease","volume":"41","author":"RPW Rouhl","year":"2010","journal-title":"Stroke"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/ATVBAHA.107.154807","article-title":"Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR\u2212\/\u2212 mice","volume":"28","author":"M van Leeuwen","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/227680a0","article-title":"Cleavage of structural proteins during the assembly of the head of bacteriophage T4","volume":"227","author":"UK Laemmli","year":"1970","journal-title":"Nature"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1111\/j.1365-2249.2008.03746.x","article-title":"anti-oxLDL antibody isotype levels, as potential markers for progressive atherosclerosis in APOE\u2212\/\u2212 and APOE\u2212\/\u2212CD40L\u2212\/\u2212 mice","volume":"154","author":"M Smook","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"3833","DOI":"10.1073\/pnas.86.10.3833","article-title":"Cloning immunoglobulin variable domains for expression by the polymerase chain reaction","volume":"86","author":"R Orlandi","year":"1989","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.4049\/jimmunol.174.2.1046","article-title":"Restricted IgA repertoire in both B\u22121 and B\u22122 cell-derived gut plasmablasts","volume":"174","author":"M Stoel","year":"2005","journal-title":"J Immunol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"W435","DOI":"10.1093\/nar\/gkh412","article-title":"IMGT\/V-QUEST, an integrated software program for immunoglobulin and T cell receptor V-J and V-D-J rearrangement analysis","volume":"32","author":"V Giudicelli","year":"2004","journal-title":"Nucleic Acids Res"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1161\/01.CIR.103.8.1164","article-title":"Induction of rapid atherogenesis by perivascular carotid collar placement in apolipoprotein E-deficient and low-density lipoprotein receptor-deficient mice","volume":"103","author":"JH von der Thusen","year":"2001","journal-title":"Circulation"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.cmet.2010.06.008","article-title":"Myeloid Type I Interferon Signaling Promotes Atherosclerosis by Stimulating Macrophage Recruitment to Lesions","volume":"12","author":"P Goossens","year":"2010","journal-title":"Cell Metabolism"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1172\/JCI200318580","article-title":"Inhibition of NF-kappaB activation in macrophages increases atherosclerosis in LDL receptor-deficient mice","volume":"112","author":"E Kanters","year":"2003","journal-title":"J Clin Invest"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1172\/JCI36800","article-title":"Oxidation-specific epitopes are dominant targets of innate natural antibodies in mice and humans","volume":"119","author":"MY Chou","year":"2009","journal-title":"J Clin Invest"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jacc.2007.03.033","article-title":"Serum myeloperoxidase levels are associated with the future risk of coronary artery disease in apparently healthy individuals: the EPIC-Norfolk Prospective Population Study","volume":"50","author":"MC Meuwese","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1172\/JCI119853","article-title":"Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy","volume":"100","author":"K Horie","year":"1997","journal-title":"J Clin Invest"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.cell.2008.02.043","article-title":"Identification of oxidative stress and Toll-like receptor 4 signaling as a key pathway of acute lung injury","volume":"133","author":"Y Imai","year":"2008","journal-title":"Cell"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.jaut.2009.05.003","article-title":"Low levels of IgM antibodies to phosphorylcholine predict cardiovascular disease in 60-year old men: Effects on uptake of oxidized LDL in macrophages as a potential mechanism","volume":"34","author":"U de Faire","year":"2010","journal-title":"Journal of Autoimmunity"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jacc.2006.11.054","article-title":"Phosphorylcholine-targeting immunization reduces atherosclerosis","volume":"50","author":"G Caligiuri","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.atherosclerosis.2011.10.002","article-title":"Immune-modulation by polyclonal IgM treatment reduces atherosclerosis in hypercholesterolemic apoE\u2212\/\u2212 mice","volume":"220","author":"FHY Cesena","year":"2012","journal-title":"Atherosclerosis"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1093\/cvr\/cvp338","article-title":"Vaccination using oxidized low-density lipoprotein-pulsed dendritic cells reduces atherosclerosis in LDL receptor-deficient mice","volume":"85","author":"KLL Habets","year":"2010","journal-title":"Cardiovascular Research"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"10089","DOI":"10.1073\/pnas.95.17.10089","article-title":"Targeted gene disruption reveals a role for natural secretory IgM in the maturation of the primary immune response","volume":"95","author":"MR Ehrenstein","year":"1998","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0068039","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,18]],"date-time":"2019-07-18T12:44:22Z","timestamp":1563453862000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0068039"}},"subtitle":[],"editor":[{"given":"Esther","family":"Lutgens","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2013,7,16]]},"references-count":41,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2013,7,16]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0068039","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,7,16]]}}}